Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study

PURPOSE: To compare the efficacy and safety of combined treatment with lenvatinib and transarterial chemoembolization (TACE) versus TACE only in patients with unresectable hepatocellular carcinoma (uHCC). METHODS: Of the 120 patients enrolled in this study, 60 patients received treatment with TACE o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhigang, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Cao, Kunkun, Ding, Ning, Liu, Li, Zhang, Xiaoli, Zhai, Jian, Qu, Zengqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286947/
https://www.ncbi.nlm.nih.gov/pubmed/33877527
http://dx.doi.org/10.1007/s12072-021-10184-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286947/
https://www.ncbi.nlm.nih.gov/pubmed/33877527
http://dx.doi.org/10.1007/s12072-021-10184-9

Ejemplares similares